Merck defeats profits expectations, rears purchases outlook on strong need for leading medications like Keytruda - CNBC

.Merck trumps earnings desires, raises purchases overview on strong requirement for leading drugs like Keytruda CNBCMerck &amp Co. (MRK US) Beats Revenue Forecasts as Keytruda Purchases Increase BloombergMerck Inventory: Pharma Giant Posts Powerful End Results, Yet Overview Drops Short Real estate investor's Business DailyMerck Announces Second-Quarter 2024 Financial Results Yahoo FinanceMerck beats revenue as well as sales desires amid Keytruda asset, yet provides blended full-year outlook MarketWatch.